CSI Market
Sign In | Register

Dynavax Technologies (DVAX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access DVAX quarterly Cash Flow →
Cash flow patterns shown here provide context for understanding Dynavax Technologies's ability to sustain operations and capital deployment.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Dec 31 2023) (Dec 31 2022) (Dec 31 2021) (Dec 31 2020)
Operating Activities
Income27.31
Depreciation & amortization4.63
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Business Exit Costs0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase-16.77
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation52.62
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.00
Increase Decrease In Prepaid Expense And Other Current Assets-
Accretion Of Debt Discounts Related To Debt Financing-
Accretion Of End Of Term Payment Related To Debt Financing-
Cash Settled Portion Of Stock Based Compensation Expense-
Cost Of Goods And Services Sold Amortization-
Write Off Of Assets In Progress-
Operating Lease Right Of Use Asset Amortization-
Available For Sale Securities Gross Realized Gain Loss Net-
Gains Losses On Sales Of Assets-
Increase Decrease In Prepaid Manufacturing-
Cepi Accrual See Note-
Amortization Of Right Of Use Assets And Loss On Disposal Of Property And Equipment-
Operating Lease Right Of Use Asset Amortization Expense3.43
Bad Debt Expense-
Non Cash Interest Expense1.16
Sublease Loss4.81
Increase Decrease In Lease Liabilities-4.39
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts and Other Receivables-2.37
Increase (Decrease) in Accounts Payable3.90
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities11.03
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-3.11
Other Working Capital-1.19
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-14.55
Discontinued operations0.00
Net Cash flow from Operating Activities66.51
Investing Activities
Capital Expenditures-6.35
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Available-for-sale Securities512.38
Payments to Acquire Marketable Securities-524.06
Real Estate Investments0.00
Proceeds From Maturities Prepayments And Calls Of Marketable Securities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-18.04
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-98.24
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Common Stock And Warrants Net-
Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net-
Tax Withholdings Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net-
Proceeds Withholdings From Exercise Of Stock Options And Restricted Stock Awards Net-
Proceeds From Exercise Of Stock Options And Restricted Stock Awards Net5.53
Payments For Purchase Of Capped Call Options-
Payments For Taxes Related To Net Share Settlement Of Rsus-9.31
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-102.02
Effect of exchange rate on cash flow-0.86
Discontinued operations0.00
Free Cash Flow60.16
Total Cash Flow-54.40
4 historic quarters locked

Sign in to unlock the full Dynavax Technologies cash flow history.

Sign In Create Free Account

About Dynavax Technologies Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K (Period: 20241231)
  • Filed with the SEC: February 20, 2025
  • Source: dvax-20241231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001029142-25-000049

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License